X-Square Capital’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

X-Square Capital’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-613	Closed	-$60K	–	145
2023 Q1	$60K	Sell	613 -3	-0.5%	-$407	0.04%	142
2022 Q4	$87K	Hold	616	–	–	0.05%	142
2022 Q3	$86K	Hold	616	–	–	0.05%	139
2022 Q2	$83K	Sell	616 -40	-6%	-$6.81K	0.05%	143
2022 Q1	$206K	Sell	656 -226	-26%	-$85.2K	0.11%	136
2021 Q4	$635K	Sell	882 -432	-33%	-$414K	0.32%	89
2021 Q3	$1.45M	Buy	1,314 +475	+57%	+$584K	0.75%	46
2021 Q2	$1.24M	Sell	839 -5	-0.6%	-$6.94K	0.59%	56
2021 Q1	$1.33M	Buy	844 +637	+308%	+$1.49M	0.62%	45
2020 Q4	$416K	Hold	207	–	–	0.22%	82
2020 Q3	$222K	Buy	+207	New	+$237K	0.16%	85

Other funds holding LABU

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Gainplan Bloomfield Hills, Michigan $254M AUM 25.62% 1-Year Est. Return

X-Square Capital's LABU Position: Q2 2023 in Review

X-Square Capital sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2023, closing a stake of 613 shares — an estimated $60K sold.

X-Square Capital first reported a position in LABU in Q3 2020 and held it in 11 quarters. The position peaked at $1.45M in Q3 2021. 51 funds tracked by Wall St. Rank hold LABU as of Q2 2023.

X-Square Capital reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2023 after selling out during the quarter.
X-Square Capital sold 613 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2023, an estimated $60K.
X-Square Capital first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2020 and held it in 11 quarters.
X-Square Capital's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $1.45M in Q3 2021.
51 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2023.

Based on X-Square Capital's 13F filing for Q2 2023, filed 14 Aug 2023.